Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  AVEO Pharmaceuticals, Inc.    AVEO   US0535881090

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

AVEO Pharmaceuticals, Inc. : Announces Webcast and Conference Call

01/02/2012| 04:05pm US/Eastern
Recommend:
0

AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that the AVEO management team will host a conference call on Tuesday, January 3, 2012 at 8:30 a.m. (ET). The call can be accessed by dialing 1-866-825-3354 (domestic) or 1-617-213-8063 (international) five minutes prior to the start of the call and providing the passcode 17542026. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), providing the passcode 21404848.

The live, listen-only webcast of the conference call can be accessed by visiting the investors section of the AVEO website at http://investor.aveopharma.com. A replay of the webcast will be archived on the company's website for two weeks following the call.

About AVEO

AVEO Pharmaceuticals (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients' lives. AVEO's proprietary Human Response Platform? provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company's website at www.aveopharma.com.

Investor Contact:
AVEO Pharmaceuticals, Inc.
Monique Allaire, 617-299-5810
or
Media Contact:
Pure Communications, Inc.
Dan Budwick, 973-271-6085


© Business Wire 2012
Recommend :
0
Partner Area
React to this article
 
Latest news on AVEO PHARMACEUTICALS, INC.
7h agoDJU.S. HOT STOCK FUTURES: Hot stocks to watch
4d ago AVEO PHARMACEUTICALS, INC.: Law Offices of Todd M. Garber Announces Investigati..
05/17 AVEO PHARMACEUTICALS, INC.: Sued by Investor
05/15 AVEO PHARMACEUTICALS, INC.: AVEO and Astellas Announce Presentations of Tivozan..
05/14 AVEO PHARMACEUTICALS, INC.: Glancy Binkow & Goldberg LLP Announces Class Action..
05/14 AVEO PHARMACEUTICALS, INC.: Abraham, Fruchter & Twersky, LLP Announces That a C..
05/10 AVEO PHARMACEUTICALS, INC.: Bernstein Liebhard LLP Announces That A Securities ..
05/02 AVEO PHARMACEUTICALS, INC.: Shareholder Rights Law Firm Johnson & Weaver, LLP A..
05/02 AVEO PHARMACEUTICALS, INC.: AVEO and Astellas Report FDA Oncologic Drug Advisor..
05/02 AVEO PHARMACEUTICALS, INC.: Trading of AVEO Common Stock Halted
Advertisement
Chart
Duration : Period :
AVEO Pharmaceuticals, Inc. Technical Analysis Chart | AVEO | US0535881090 | 4-Traders
Income Statement Evolution
AVEO Pharmaceuticals, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.